Clinical Trial Update: Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial comparing intracameral levofloxacin 0.5% to intracameral cefuroxime for postoperative endophthalmitis; status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis Postoperative

Drugs mentioned

• cefuroxime (cefuroxime)
• lev A (levofloxacin)

Snippet

Sponsor: National University of Malaysia | Conditions: Endophthalmitis Postoperative | Phase 1, Phase 2 | Status: UNKNOWN